Skip to the page

Data / Drug companies / Xiromed, LLC

Xiromed, LLC: 94 products in the FDA NDC directory, labeler code 70700

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Xiromed, LLC (labeler code 70700) lists 94 products in the FDA National Drug Code Directory, covering 47 finished drugs by generic name. By type: 93 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 28, 2025.

The request: Watch Xiromed, LLC (FDA labeler code 70700): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
70700
Products in commercial distribution
94
Packages
124
Finished drugs by generic name
47
Prescription products
93
Over the counter products
1
Controlled substance products
Schedule III 4
Flagged as original packager
84 of 84 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
December 1, 2017
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)94100%

Products by type

TypeProductsShare
Prescription drugs9398.9%
Over the counter drugs11.1%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Kit2627.7%
Injection1718.1%
Tablet1617%
Injection, solution99.6%
Capsule, delayed release55.3%
Gel55.3%
Ointment33.2%
Capsule22.1%
Aerosol, foam22.1%
Injection, powder, lyophilized, for solution11.1%
Powder11.1%
Insert11.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Methylene blue70700-328InjectionGeneric drugs (ANDA)September 28, 2025
Progesterone vaginal insert70700-201InsertGeneric drugs (ANDA)September 23, 2025
Phytonadione70700-331Injection, emulsionGeneric drugs (ANDA)August 28, 2025
Omeprazole70700-151Capsule, delayed releaseGeneric drugs (ANDA)January 30, 2025
Abigale70700-330TabletGeneric drugs (ANDA)January 29, 2025
Meleya70700-317TabletGeneric drugs (ANDA)January 29, 2025
Orquidea70700-316TabletGeneric drugs (ANDA)January 29, 2025
Luizza 1.5/3070700-314TabletGeneric drugs (ANDA)January 29, 2025
Luizza 1/2070700-313TabletGeneric drugs (ANDA)January 29, 2025
Rosyrah70700-312KitGeneric drugs (ANDA)January 29, 2025
Xarah fe70700-310KitGeneric drugs (ANDA)January 29, 2025
Feirza 1.5/30 tm70700-309KitGeneric drugs (ANDA)January 29, 2025
Xelria Fe70700-308KitGeneric drugs (ANDA)January 29, 2025
Feirza 1/2070700-307KitGeneric drugs (ANDA)January 29, 2025
Galbriela70700-306KitGeneric drugs (ANDA)January 29, 2025
Valtya 1/5070700-305KitGeneric drugs (ANDA)January 29, 2025
Valtya 1/3570700-304KitGeneric drugs (ANDA)January 29, 2025
Abigale lo70700-303TabletGeneric drugs (ANDA)January 29, 2025
Introvale70700-208KitGeneric drugs (ANDA)January 29, 2025
Lojaimiess70700-207KitGeneric drugs (ANDA)January 29, 2025
Jaimiess70700-206KitGeneric drugs (ANDA)January 29, 2025
Gallifrey70700-326TabletGeneric drugs (ANDA)September 6, 2024
Ganirelix Acetate70700-327InjectionGeneric drugs (ANDA)April 1, 2024
Medroxyprogesterone Acetate70700-315Injection, suspensionGeneric drugs (ANDA)March 12, 2024
Guanfacine Hydrochloride70700-302TabletGeneric drugs (ANDA)February 24, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.